Log In
Print
BCIQ
Print
Print this Print this
 

Fzd8-Fc (OMP-54F28)

  Manage Alerts
Collapse Summary General Information
Company OncoMed Pharmaceuticals Inc.
DescriptionWnt signaling antagonist
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today